Literature DB >> 24561790

Hepatitis B or C virus infection and risk of non-Hodgkin lymphoma among solid organ transplant recipients.

Lindsay M Morton1, Todd M Gibson, Christina A Clarke, Charles F Lynch, Dennis D Weisenburger, Eric A Engels.   

Abstract

Entities:  

Keywords:  HBV; HCV; NHL after solid organ transplantation

Mesh：

Year:  2014        PMID： 24561790      PMCID： PMC4008103          DOI： 10.3324/haematol.2013.101600

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   11.047


× No keyword cloud information.
  15 in total

1.  Hepatitis B virus reactivation is a risk factor for development of post-transplant lymphoproliferative disease after liver transplantation.

Authors:  Aibin Zhang; Min Zhang; Yan Shen; Weilin Wang; Shusen Zheng
Journal:  Clin Transplant       Date:  2009-08-02       Impact factor: 2.863

2.  Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study.

Authors:  Eric A Engels; Eo Rin Cho; Sun Ha Jee
Journal:  Lancet Oncol       Date:  2010-08-03       Impact factor: 41.316

3.  Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience.

Authors:  Daniele Vallisa; Patrizia Bernuzzi; Luca Arcaini; Stefano Sacchi; Vittorio Callea; Roberto Marasca; Antonio Lazzaro; Elena Trabacchi; Elisa Anselmi; Anna Lisa Arcari; Carlo Moroni; Raffaella Bertè; Mario Lazzarino; Luigi Cavanna
Journal:  J Clin Oncol       Date:  2005-01-20       Impact factor: 44.544

4.  Hepatitis B virus infection and risk of lymphoma: results of a serological analysis within the European case-control study Epilymph.

Authors:  Nikolaus Becker; Paul Schnitzler; Paolo Boffetta; Paul Brennan; Lenka Foretova; Marc Maynadié; Alexandra Nieters; Anthony Staines; Yolanda Benavente; Pierluigi Cocco; Silvia de Sanjose
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-06       Impact factor: 4.553

5.  Hepatitis C infection is not associated with systemic HIV-associated non-Hodgkin's lymphoma: a cohort study.

Authors:  Laura Waters; Justin Stebbing; Sundhiya Mandalia; Anne Marie Young; Mark Nelson; Brian Gazzard; Mark Bower
Journal:  Int J Cancer       Date:  2005-08-10       Impact factor: 7.396

Review 6.  Biological and clinical implications of HBV infection in peripheral blood mononuclear cells.

Authors:  Patrizia Pontisso; Laura Vidalino; Santina Quarta; Angelo Gatta
Journal:  Autoimmun Rev       Date:  2008-08-13       Impact factor: 9.754

7.  Hepatitis C virus lymphotropism and peculiar immunological phenotype: effects on natural history and antiviral therapy.

Authors:  Paolo Conca; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2009-05-21       Impact factor: 5.742

8.  Hepatitis C virus infection and risk of posttransplantation lymphoproliferative disorder among solid organ transplant recipients.

Authors:  Lindsay M Morton; Ola Landgren; Nilanjan Chatterjee; David Castenson; Ruth Parsons; Robert N Hoover; Eric A Engels
Journal:  Blood       Date:  2007-09-12       Impact factor: 22.113

9.  Hepatitis C virus and non-Hodgkin's lymphoma: Findings from the Swiss HIV Cohort Study.

Authors:  S Franceschi; J Polesel; M Rickenbach; L Dal Maso; N M Probst-Hensch; C Fux; M Cavassini; B Hasse; A Kofler; B Ledergerber; P Erb; G M Clifford
Journal:  Br J Cancer       Date:  2006-11-14       Impact factor: 7.640

10.  Risk of lymphoma subtypes after solid organ transplantation in the United States.

Authors:  C A Clarke; L M Morton; C Lynch; R M Pfeiffer; E C Hall; T M Gibson; D D Weisenburger; O Martínez-Maza; S K Hussain; J Yang; E T Chang; E A Engels
Journal:  Br J Cancer       Date:  2013-06-11       Impact factor: 9.075
View more
  1 in total

1.  Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study.

Authors:  Todd M Gibson; Lindsay M Morton; Meredith S Shiels; Christina A Clarke; Eric A Engels
Journal:  AIDS       Date:  2014-09-24       Impact factor: 4.177
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.